Eupraxia Pharmaceuticals (EPRX) Cash & Equivalents (2022 - 2026)
Eupraxia Pharmaceuticals' Cash & Equivalents was $52.43 million in the quarter ended Jun 30, 2026, up 165.2% from $19.77 million a year earlier but down 10.4% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Cash & Equivalents (2022 - 2026) Analysis & Trends
As of Dec 31, 2025, Cash & Equivalents at Eupraxia Pharmaceuticals came in at $80.56 million, up 143.4% from the prior year.
- Cash & Equivalents has now increased for three consecutive years, with a three-year compound annual growth rate of 64.0% (years ended Dec 2022 to Dec 2025).
- In earlier years, Cash & Equivalents was $33.1 million in the year ended Dec 31, 2024 (+71.1%), $19.34 million in the year ended Dec 31, 2023 (+5.9%) and $18.26 million in the year ended Dec 31, 2022.
- Quarterly Cash & Equivalents has moved between $8.66 million (the quarter ended Sep 30, 2024) and $88.96 million (the quarter ended Sep 30, 2025) over five years.
- Compared with a year earlier, Cash & Equivalents has increased for four straight quarters, with growth averaging 197.3% over the last seven quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was the quarter ended Sep 30, 2025 (growth of 927.0%); the worst was the quarter ended Mar 31, 2025 (a decline of 23.5%).
- Per Business Quant data, EPRX's Cash & Equivalents in the three quarters before the quarter ended Jun 30, 2026 was $58.5 million (quarter ended Mar 31, 2026), $80.56 million (quarter ended Dec 31, 2025) and $88.96 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Eupraxia Pharmaceuticals | 312.86 Mn | 311.25 Mn | - | 52.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52.43 Mn |
| Mar 31, 2026 | 58.50 Mn |
| Dec 31, 2025 | 80.56 Mn |
| Sep 30, 2025 | 88.96 Mn |
| Jun 30, 2025 | 19.77 Mn |
| Mar 31, 2025 | 27.45 Mn |
| Dec 31, 2024 | 33.10 Mn |
| Sep 30, 2024 | 8.66 Mn |
| Jun 30, 2024 | 23.32 Mn |
| Mar 31, 2024 | 35.91 Mn |
| Dec 31, 2023 | 19.34 Mn |
| Dec 31, 2022 | 18.26 Mn |
API Access
Eupraxia Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();